Bayer Pledges to Continue Yaz Lawsuit Settlements For Now

Share Article

The Yaz Resource Center is the Web’s largest source for information on Yaz side effects, research and legal news. Visit http://www.YazLawsuit.com

yaz lawsuit
Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal rights.

The Yaz Resource Center, a patient advocacy group, is alerting women who have suffered side effects after taking the birth control drugs Yaz or Yasmin that the maker of the drugs, Bayer, has pledged more funds to resolve claims by those injured. However, the time to file a claim is limited.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Yaz Resource Center or speak with a lawyer about their legal rights.

On October 25, 2011, the British Medical Journal published a study from researchers at The University of Copenhagen which related the hormone in Yaz to blood clots.

The FDA followed on October 27, 2011, releasing its own study of more than 800,000 women titled "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints" which found drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.

On May 31, 2012, the Institute for Safe Medicine Practices published its QuarterWatch report which ranked Yaz and Yasmin as the second-worst drugs in 2011 for the number of complications reported to the FDA.

Due to the number of patients that have filed a Yaz lawsuit, a federal Multi-District Litigation court was established in Illinois to handle the claims. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100). The court estimates more than 11,000 patients have filed a claim so far.

Bloomberg News reported on July 31st that Bayer has settled nearly 1900 of these Yaz lawsuits so far for more than $400 million, at an average of around $212,000. The article also indicates Bayer has more than doubled its reserves to settle cases to over $610 million. This could be positive news for those injured who have yet to file a claim.

Anyone affected by blood clots, stroke, DVT or pulmonary embolism after taking Yaz should learn their legal rights as soon as possible and find out if a Yaz lawsuit is the right option.

The Yaz Resource Center cautions victims that only lawyers with experience in defective drug litigation may be able to settle their case. The Resource Center only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on research, side effects and Yaz litigation news related to the drug, or to speak with a lawyer, visit http://www.YazLawsuit.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
Visit website